Source: Eur Respir J, 57 (6) 2003036; 10.1183/13993003.03036-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Saisakul Chernbumroong, Janice Johnson, Nishant Gupta, Suzanne Miller, Francis X. McCormack, Jonathan M. Garibaldi, Simon R. Johnson. Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis. Eur Respir J, 57 (6) 2003036; 10.1183/13993003.03036-2020

Member's Comments

No comment yet.

Related content which might interest you: Development of a multivariate model to predict clinical deterioration in pulmonary sarcoidosis Source: International Congress 2017 – Novel and old entities Year: 2017 Machine learning algorithm for the diagnosis of pulmonary embolism: a proof of concept study Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020 Predicting the course of sarcoidosis with clinical factors Source: Eur Respir J 2005; 26: Suppl. 49, 32s Year: 2005 Sarcoidosis: imagiological findings and their impact on the disease outcome Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Bronchiectasis severity assessment tools to predict clinical outcomes in the Indian Bronchiectasis Registry Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Severe sarcoidosis: clinical features and management Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort Source: Eur Respir J, 57 (6) 2002591; 10.1183/13993003.02591-2020 Year: 2021 Clinically applicable machine learning prediction model for pulmonary hypertension due to left heart disease Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension Year: 2021 Clinical manifestations and prediction rules in patients with pulmonary embolism and prior respiratory disease Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1602520; DOI: 10.1183/13993003.02520-2016 Year: 2017 The presentation and outcome of chronic pulmonary lobar collapse in children Source: International Congress 2014 – Neonatal and paediatric intensive care Year: 2014 Applying machine learning and pulmonary function data to detect interstitial lung disease in systemic sclerosis. Source: International Congress 2017 – Best abstracts in lung function Year: 2017 Use of Machine learning to predict asthma exacerbations Source: Virtual Congress 2020 – Digital technologies in airway diseases Year: 2020 Granulomatous lung disease in common variable immunodeficiency: practical issues and difficulties in diagnosis and management Source: Eur Respir J 2005; 26: Suppl. 49, 376s Year: 2005 Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Pulmonary function evaluation in advanced Parkinson‘s disease Source: Eur Respir J 2006; 28: Suppl. 50, 201s Year: 2006